Bruno Gagnon
Corporate Officer/Principal chez OPTHEA LIMITED
Profil
Bruno Gagnon is a professional with experience in various firms.
He is currently working as Senior Vice President-Global Clinical Operations at Opthea Ltd.
He has previously worked as Vice President-Clinical Operations at BioMarin Pharmaceutical, Inc. and as Senior Vice President-Development Operations at Eidos Therapeutics, Inc. Mr. Gagnon has completed his graduate degree from the University of Montréal and his undergraduate degree from Université Laval.
Postes actifs de Bruno Gagnon
| Sociétés | Poste | Début |
|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 01/07/2022 |
Anciens postes connus de Bruno Gagnon
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Directeur des opérations | - |
| EIDOS THERAPEUTICS, INC. | Directeur des opérations | - |
Formation de Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |